BioCryst Pharmaceuticals Inc
F:BO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioCryst Pharmaceuticals Inc
F:BO1
|
US |
|
Eniro Group AB
F:EN8A
|
SE |
|
S
|
Sagax AB
F:EFE
|
SE |
Shareholder Yield
Current shareholder yield for
BO1 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
BO1 Price
BioCryst Pharmaceuticals Inc
| Average Annual Return | -9.83% |
| Standard Deviation of Annual Returns | 34.72% |
| Max Drawdown | -77% |
| Market Capitalization | 2.1B EUR |
| Shares Outstanding | 206 347 000 |
| Percentage of Shares Shorted |
N/A
|